John L. Slebir
General Counsel at DYNAVAX TECHNOLOGIES CORPORATION
Net worth: 112 649 $ as of 2024-04-29
Profile
John L.
Slebir is currently the Senior Vice President & General Counsel at Dynavax Technologies Corp.
Prior to this, he worked as the Secretary & General Counsel at VIVUS, Inc. from 2009 to 2021.
He also worked as an Attorney at Wilson Sonsini Goodrich & Rosati PC from 1999 to 2011.
Additionally, he served as the General Counsel at Cardiva Medical, Inc. Mr. Slebir received his undergraduate degree from San Diego State University and his graduate degree from The Santa Clara University School of Law.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2024-03-28 | 10,085 ( 0.01% ) | 112 649 $ | 2024-04-29 |
John L. Slebir active positions
Companies | Position | Start |
---|---|---|
DYNAVAX TECHNOLOGIES CORPORATION | General Counsel | 2021-06-27 |
Former positions of John L. Slebir
Companies | Position | End |
---|---|---|
VIVUS, INC. | General Counsel | 2021-06-30 |
Wilson Sonsini Goodrich & Rosati PC
Wilson Sonsini Goodrich & Rosati PC Miscellaneous Commercial ServicesCommercial Services Wilson Sonsini Goodrich & Rosati PC provides legal services. Its services include corporate law and governance, public and private offerings of equity and debt securities, mergers and acquisitions, securities class action litigation, intellectual property litigation, antitrust counseling and litigation, joint ventures and strategic alliances, technology licensing and other intellectual property transactions, tax, and employee benefits and employment law. The company was founded in 1961 and is headquartered in Palo Alto, CA. | Corporate Officer/Principal | 2010-12-31 |
Cardiva Medical, Inc.
Cardiva Medical, Inc. Medical SpecialtiesHealth Technology Cardiva Medical, Inc. designs and develops vascular access management products. It offers VASCADE, an extravascular closure device designed to increase the comfort and safety of vascular closure for patients; and Catalyst, a device that supports the body's natural healing process by enhancing the vessel's inherent natural elastic recoil, tissue apposition and coagulation. The company was founded by Zia Yassinzadeh and Augustine Y. Lien in July 2002 and is headquartered in Santa Clara, CA. | General Counsel | - |
Training of John L. Slebir
San Diego State University | Undergraduate Degree |
The Santa Clara University School of Law | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
DYNAVAX TECHNOLOGIES CORPORATION | Health Technology |
Private companies | 3 |
---|---|
Wilson Sonsini Goodrich & Rosati PC
Wilson Sonsini Goodrich & Rosati PC Miscellaneous Commercial ServicesCommercial Services Wilson Sonsini Goodrich & Rosati PC provides legal services. Its services include corporate law and governance, public and private offerings of equity and debt securities, mergers and acquisitions, securities class action litigation, intellectual property litigation, antitrust counseling and litigation, joint ventures and strategic alliances, technology licensing and other intellectual property transactions, tax, and employee benefits and employment law. The company was founded in 1961 and is headquartered in Palo Alto, CA. | Commercial Services |
VIVUS, Inc.
VIVUS, Inc. Pharmaceuticals: MajorHealth Technology VIVUS, Inc. engaged in the development and commercialization of novel therapeutic products. The firm’s products were indicated for the treatment of obese and overweight patients, exocrine pancreatic insufficiency, and erectile dysfunction. Its products include PANCREAZE, Qsymia, and STENDRA/SPEDRA. The company was founded by Virgil A. Place in April 16, 1991 and it was headquartered in Campbell, CA. | Health Technology |
Cardiva Medical, Inc.
Cardiva Medical, Inc. Medical SpecialtiesHealth Technology Cardiva Medical, Inc. designs and develops vascular access management products. It offers VASCADE, an extravascular closure device designed to increase the comfort and safety of vascular closure for patients; and Catalyst, a device that supports the body's natural healing process by enhancing the vessel's inherent natural elastic recoil, tissue apposition and coagulation. The company was founded by Zia Yassinzadeh and Augustine Y. Lien in July 2002 and is headquartered in Santa Clara, CA. | Health Technology |
- Stock Market
- Insiders
- John L. Slebir